- cafead   Aug 12, 2021 at 12:32: PM
via
article source
- Moderna's management recently stated that the company wants to expand its platform into gene editing.
- There are several reasons why Editas Medicine could be an attractive acquisition target for Moderna.
- It's possible, though, that Moderna could prefer to buy a preclinical-stage biotech or partner with another gene-editing company instead of buying it.
article source